JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB62322

Anti-SHP2 (phospho Y542) antibody [EP508(2)Y]

Be the first to review this product! Submit a review

|

(39 Publications)

Rabbit Recombinant Monoclonal SHP2 phospho Y542 antibody. Suitable for IP, WB, ICC/IF and reacts with Mouse, Human samples. Cited in 39 publications.

View Alternative Names

PTP2C, SHPTP2, PTPN11, Tyrosine-protein phosphatase non-receptor type 11, Protein-tyrosine phosphatase 1D, Protein-tyrosine phosphatase 2C, SH-PTP2, SH-PTP3, PTP-1D, PTP-2C, SHP-2, Shp2

5 Images
Immunocytochemistry/ Immunofluorescence - Anti-SHP2 (phospho Y542) antibody [EP508(2)Y] (AB62322)
  • ICC/IF

Unknown

Immunocytochemistry/ Immunofluorescence - Anti-SHP2 (phospho Y542) antibody [EP508(2)Y] (AB62322)

ab62322 staining SHP2 in THP-1 cells ( Human monocytic leukaemia cell line) by ICC/IF (immunocytochemistry/immunofluorescence). Cells were fixed with 4% Paraformaldehyde and permeabilized with 0.1% TritonX-100. Samples were incubated with purified ab62322 at 8.8 μg/ml. Secondary antibody used was AlexaFluor®488 Goat anti-Rabbit (ab150077) at 2 μg/ml. Anti-alpha Tubulin antibody [DM1A] - Microtubule Marker (Alexa Fluor® 594)( ab195889) used as counterstain at 2.5 μg/ml . DAPI was used as nuclear counterstain. Confocal image showing the expression was increased after treatment with TPA 200nM for 24h and PDGF 50ng/ml for 30min, the signal decreased after treatment with Lambda Protein Phosphatase 31℃ for 2h.

This image was generated using the unpurified version of the product.

Immunoprecipitation - Anti-SHP2 (phospho Y542) antibody [EP508(2)Y] (AB62322)
  • IP

Unknown

Immunoprecipitation - Anti-SHP2 (phospho Y542) antibody [EP508(2)Y] (AB62322)

ab62322 (purified) at 1 : 30 dilution (2μg) immunoprecipitating SHP2 in NIH/3T3 treated with 50ng/ml PDGF for 40min whole cell lysate.
Lane 1 (input) : NIH/3T3 (Mouse embryonic fibroblast) treated with 50ng/ml PDGF for 40min whole cell lysate 10μg
Lane 2 (+) : ab62322 & NIH/3T3 treated with 50ng/ml PDGF for 40min whole cell lysate
Lane 3 (-) : Rabbit monoclonal IgG (ab172730) instead of ab62322 in NIH/3T3 treated with 50ng/ml PDGF for 40min whole cell lysate
For western blotting, VeriBlot for IP Detection Reagent (HRP) (ab131366) was used for detection at 1 : 1000 dilution.
Blocking and diluting buffer : 5% NFDM/TBST.

All lanes:

Immunoprecipitation - Anti-SHP2 (phospho Y542) antibody [EP508(2)Y] (ab62322)

Predicted band size: 68 kDa

false

Western blot - Anti-SHP2 (phospho Y542) antibody [EP508(2)Y] (AB62322)
  • WB

Lab

Western blot - Anti-SHP2 (phospho Y542) antibody [EP508(2)Y] (AB62322)

Blocking and diluting buffer used was 5% NFDM/TBST.

Purified batch of ab62322 was used.

This image was generated using the unpurified version of the product.

All lanes:

Western blot - Anti-SHP2 (phospho Y542) antibody [EP508(2)Y] (ab62322) at 1/200 dilution

Lane 1:

THP-1 (Human monocytic leukemia monocyte) whole cell lysates at 15 µg

Lane 2:

THP-1 (Human monocytic leukemia monocyte) treated with Phorbol-12-myristate-13-acetate and platelet-derived growth factor at 15 µg

Lane 3:

THP-1 (Human monocytic leukemia monocyte) treated with Phorbol-12-myristate-13-acetate and platelet-derived growth factor, then the membrane was incubated with phosphatase at 15 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution

Predicted band size: 68 kDa

Observed band size: 68 kDa

false

Western blot - Anti-SHP2 (phospho Y542) antibody [EP508(2)Y] (AB62322)
  • WB

Unknown

Western blot - Anti-SHP2 (phospho Y542) antibody [EP508(2)Y] (AB62322)

Beta Tubulin has been included as a loading control.

This image was generated using the unpurified version of the product.

All lanes:

Western blot - Anti-SHP2 (phospho Y542) antibody [EP508(2)Y] (ab62322) at 1/50000 dilution

Lane 1:

NIH/3T3 cell lysates; untreated at 10 µg

Lane 2:

NIH/3T3 cell lysates; treated with PDGF at 10 µg

Secondary

All lanes:

goat anti-rabbit HRP conjugated, at 1/2000 dilution

Predicted band size: 68 kDa

Observed band size: 68 kDa

false

Western blot - Anti-SHP2 (phospho Y542) antibody [EP508(2)Y] (AB62322)
  • WB

Lab

Western blot - Anti-SHP2 (phospho Y542) antibody [EP508(2)Y] (AB62322)

All lanes:

Western blot - Anti-SHP2 (phospho Y542) antibody [EP508(2)Y] (ab62322) at 1/1000 dilution

Lane 1:

NIH/3T3 (Mouse embryonic fibroblast) whole cell lysates at 15 µg

Lane 2:

NIH/3T3 (Mouse embryonic fibroblast) treated with 40ng/ml PDGF for 40 minutes whole cell lysates at 15 µg

Lane 3:

NIH/3T3 (Mouse embryonic fibroblast) treated with 40ng/ml PDGF for 40 minutes then incubated with phosphatase at 15 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution

Predicted band size: 68 kDa

Observed band size: 68 kDa

false

  • Carrier free

    Anti-SHP2 (phospho Y542) antibody [EP508(2)Y] - BSA and Azide free

  • 578 PE

    PE Anti-SHP2 (phospho Y542) antibody [EP508(2)Y]

  • 660 APC

    APC Anti-SHP2 (phospho Y542) antibody [EP508(2)Y]

  • 565 Alexa Fluor® 555

    Alexa Fluor® 555 Anti-SHP2 (phospho Y542) antibody [EP508(2)Y]

  • 665 Alexa Fluor® 647

    Alexa Fluor® 647 Anti-SHP2 (phospho Y542) antibody [EP508(2)Y]

  • 617 Alexa Fluor® 594

    Alexa Fluor® 594 Anti-SHP2 (phospho Y542) antibody [EP508(2)Y]

  • 519 Alexa Fluor® 488

    Alexa Fluor® 488 Anti-SHP2 (phospho Y542) antibody [EP508(2)Y]

Key facts

Host species

Rabbit

Clonality

Monoclonal

Clone number

EP508(2)Y

Isotype

IgG

Carrier free

No

Reacts with

Mouse, Human

Applications

IP, ICC/IF, WB

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IP" : {"fullname" : "Immunoprecipitation", "shortname":"IP"}, "FlowCyt" : {"fullname" : "Flow Cytometry", "shortname":"Flow Cyt"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IP-species-checked": "guaranteed", "IP-species-dilution-info": "", "IP-species-notes": "", "FlowCyt-species-checked": "notRecommended", "FlowCyt-species-dilution-info": "", "FlowCyt-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000", "WB-species-notes": "<p><strong>For unpurified use at 1/50000- 1/100000.</strong></p>", "ICCIF-species-checked": "testedAndGuaranteed", "ICCIF-species-dilution-info": "1/100 - 1/250", "ICCIF-species-notes": "<p></p>" }, "Mouse": { "IP-species-checked": "testedAndGuaranteed", "IP-species-dilution-info": "1/30", "IP-species-notes": "<p><strong>For unpurified use at 1/40</strong></p>", "FlowCyt-species-checked": "notRecommended", "FlowCyt-species-dilution-info": "", "FlowCyt-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000", "WB-species-notes": "<p><strong>For unpurified use at 1/50000- 1/100000.</strong></p>", "ICCIF-species-checked": "guaranteed", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "" } } }

Product details

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

Species reactivity
Rat: We have preliminary internal testing data to indicate this antibody may not react with this species.
Please contact us for more information.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
pH: 7.2 - 7.4 Preservative: 0.01% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Storage information
Stable for 12 months at -20°C

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

SHP2 also known as PTPN11 is a protein tyrosine phosphatase with a molecular mass of approximately 68 kDa. It is expressed in various tissues including the heart liver and immune cells. SHP2 belongs to the non-receptor class of protein tyrosine phosphatases and plays a critical role in cell signaling by acting as a regulator of signal transduction processes. SHP2 mediates these processes by dephosphorylating specific phosphotyrosine residues on target proteins influencing various cellular functions like proliferation differentiation and survival.
Biological function summary

The role of SHP2 extends to involvement in several signaling cascades such as the Ras/MAPK and PI3K/AKT pathways. It functions as an essential component within protein complexes that facilitate cell communication and response to external signals. The protein modulates growth factor signaling and cytokine signaling highlighting its significance in normal cell function and development. SHP2's statement in signaling processes makes it an important regulator of cellular dynamics.

Pathways

SHP2 participates in the Ras/MAPK and PI3K/AKT signaling pathways which are important for regulating cell growth survival and differentiation. Within these pathways SHP2 interacts with various signaling molecules including Grb2 Sos and Gab family adaptors. These interactions coordinate cellular responses to growth factors and other extracellular cues ensuring proper pathway activation and control. By serving as a critical mediator SHP2 integrates signals that are necessary for appropriate cellular outcomes.

SHP2 is associated with several conditions such as Noonan syndrome and various cancers. Mutations in the PTPN11 gene which encodes SHP2 often result in aberrant signaling that leads to developmental anomalies or tumorigenesis. In Noonan syndrome the mutated SHP2 protein results in disrupted Ras/MAPK pathway signaling. As for cancers SHP2 is often found to be overactive leading to enhanced cell proliferation and survival. In these contexts SHP2 is interconnected with other proteins like RAS and RAF which also contribute to oncogenic pathway activation and disease progression.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Acts downstream of various receptor and cytoplasmic protein tyrosine kinases to participate in the signal transduction from the cell surface to the nucleus (PubMed : 10655584, PubMed : 14739280, PubMed : 18559669, PubMed : 18829466, PubMed : 26742426, PubMed : 28074573, PubMed : 32184441). Positively regulates MAPK signal transduction pathway (PubMed : 28074573). Dephosphorylates GAB1, ARHGAP35 and EGFR (PubMed : 28074573). Dephosphorylates ROCK2 at 'Tyr-722' resulting in stimulation of its RhoA binding activity (PubMed : 18559669). Dephosphorylates CDC73 (PubMed : 26742426). Dephosphorylates SOX9 on tyrosine residues, leading to inactivate SOX9 and promote ossification (By similarity). Dephosphorylates tyrosine-phosphorylated NEDD9/CAS-L (PubMed : 19275884). Acts as an effector of PDCD1-mediated inhibition of T-cell response : recruited by phosphorylated PDCD1, mediating dephosphorylation of key T-cell receptor (TCR) proximal signaling molecules, leading to TCR signaling inhibition (PubMed : 32184441).
See full target information PTPN11 phospho Y542

Publications (39)

Recent publications for all applications. Explore the full list and refine your search

Signal transduction and targeted therapy 10:299 PubMed40935839

2025

Coinhibition of the MEK/RTK pathway has high therapeutic efficacy in KRAS-mutant non-small cell lung cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Jun Lu,Minjuan Hu,Yikai Zhao,Tianqing Chu,Wei Zhang,Yijia Zhou,Xinlei Cai,Jun Wu,Liang Hu,Chunlei Shi,Liwen Xiong,Aiqin Gu,Huimin Wang,Yanwei Zhang,Yuqing Lou,Runbo Zhong,Zhiqiang Gao,Hongyu Liu,Chao Zhou,Yingli Wu,Liang Zhu,Hua Zhong,Hongbin Ji,Baohui Han

Theranostics 15:7454-7466 PubMed40756348

2025

GD2-mediated impairment of macrophage phagocytosis drives pulmonary metastasis in osteosarcoma.

Applications

Unspecified application

Species

Unspecified reactive species

Yunfei He,Peng Yang,Peng Ding,Zeng Zhang,Jichuan Wu,Chunjie Wang,Guanghui Hou,Jun Ge,Quan Zhou,Zhuorun Song,Huilin Yang,Tao Liu,Shunyi Lu

Cardiology research and practice 2024:1905996 PubMed39257436

2024

Inhibiting H2AX Can Ameliorate Myocardial Ischemia/Reperfusion Injury by Regulating P53/JNK Signaling Pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Ziyang Yu,Yirong Teng,Hongbo Yang,Yudi Wang,Xichen Li,Lei Feng,Wenbo Xu,Yinglu Hao,Yanping Li

Scientific reports 14:20251 PubMed39215017

2024

MSU crystallization promotes fibroblast proliferation and renal fibrosis in diabetic nephropathy via the ROS/SHP2/TGFβ pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Jing Li,Jiwei Zhang,Xuying Zhao,Ling Tian

EMBO molecular medicine 16:1755-1790 PubMed39030302

2024

LILRB1-HLA-G axis defines a checkpoint driving natural killer cell exhaustion in tuberculosis.

Applications

Unspecified application

Species

Unspecified reactive species

Jing Wang,Qiyao Chai,Zehui Lei,Yiru Wang,Jiehua He,Pupu Ge,Zhe Lu,Lihua Qiang,Dongdong Zhao,Shanshan Yu,Changgen Qiu,Yanzhao Zhong,Bing-Xi Li,Lingqiang Zhang,Yu Pang,George Fu Gao,Cui Hua Liu

Aging 15:12264-12274 PubMed37934569

2023

Influences and mechanism of erythropoietin on the cognitive function of vascular dementia rats.

Applications

Unspecified application

Species

Unspecified reactive species

Zhipeng Tang,Xiuqin Li,Nan Yin,Ming Zhao,Qingchuan Hu,Peiyuan Lv

Journal of neuroinflammation 20:234 PubMed37828609

2023

Astrocyte interferon-gamma signaling dampens inflammation during chronic central nervous system autoimmunity via PD-L1.

Applications

Unspecified application

Species

Unspecified reactive species

Brandon C Smith,Rachel A Tinkey,Orion D Brock,Arshiya Mariam,Maria L Habean,Ranjan Dutta,Jessica L Williams

Aging 15:9877-9889 PubMed37768203

2023

Myeloid-specific knockout of SHP2 regulates PI3K/PLCγ signaling pathway to protect against early myocardial infarction injury.

Applications

Unspecified application

Species

Unspecified reactive species

Menglin Sha,Hongxing Li,Bingyan Guo,Xiaoyong Geng

Signal transduction and targeted therapy 8:236 PubMed37332010

2023

Soluble CD4 effectively prevents excessive TLR activation of resident macrophages in the onset of sepsis.

Applications

Unspecified application

Species

Unspecified reactive species

Sheng-Yuan Zhang,Qiu-Ping Xu,Li-Na Shi,Shih-Wen Li,Wei-Hong Wang,Qing-Qing Wang,Liao-Xun Lu,Hui Xiao,Jun-Hong Wang,Feng-Ying Li,Yin-Ming Liang,Si-Tang Gong,Hao-Ran Peng,Zheng Zhang,Hong Tang

Molecular oncology 17:964-980 PubMed36650715

2023

Rational combination of SHP2 and mTOR inhibition for the treatment of hepatocellular carcinoma.

Applications

Unspecified application

Species

Unspecified reactive species

Antonio Mulero-Sánchez,Christel F A Ramirez,Aimée du Chatinier,Hui Wang,Sofie J I Koomen,Ji-Ying Song,Marnix H P de Groot,Cor Lieftink,Astrid Bosma,Artur Burylo,Olaf van Tellingen,Roderick L Beijersbergen,Cun Wang,Leila Akkari,René Bernards,Sara Mainardi
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com